
Daniel Moore
1.7K posts

Daniel Moore
@armyofdan
Father, husband, scholar, educator. Director of Some Things. Peds endo. Expert in rejection and tolerance of many kinds. Physician-Scientist. T1D_life.💙


Excited to join the PSTP Pathways Webinar Week tonight at 7 PM ET! We’re focusing on Pediatrics tonight! Featuring Dr. Lisa Satlin (Mount Sinai), Dr. Daniel Moore (@armyofdan, Vanderbilt), and Dr. Ann Chahroudi (@AnnChahroudi, Emory). #PSTP


Led by @armyofdan, our diabetes immune therapy clinic helps identify presymptomatic, at-risk individuals for Type 1 diabetes intervention. He recently co-authored a study that offers updated screening recommendations for #T1D. @vumcpeds @vumcdiabetes discoveries.vanderbilthealth.com/2024/10/catch-…

The type 1 diabetes research community recently lost a brilliant, driven, and thoughtful researcher and friend in Helen Thomas. She touched my career in many ways and impacted me in a profound way. Thoughts are with her family. svi.edu.au/news-events/va…

Hot off the press: Preparing Physician–Scientists for the Future of Academic Medicine @AudreaMBurns @armyofdan @NPSCW_PedsPSTPs @bcmhouston @TexasChildrens publications.aap.org/pediatrics/art…





Did u know your child’s doctor is paid 25% less than adult docs with the same yrs of training and debt? The way we fund care in this country is backwards, leading to a dwindling pool of med grads choosing pediatrics @bvincibmc and I propose a fix here: statnews.com/2024/04/02/too…





Congratulations to my twitterless colleague Daria Esterházy & team @UChicagoImmuno on identifying the lymph node sharing in the gastrointestinal system that shapes pancreatic immunity. Checkout their creative cover page @ImmunityCP inspired by the #Chicago metro rail map.



Read the RICO indictment, Don Trumpino. They found the riggers.

As our understanding of the adaptive immune repertoire increases, we will need efficient ways to model the pathogenic potential of TCRs and phenotypes. Happy to share this new work by @leeanadenise1 and colleagues editing primary human CD8+ T cells.
